Details of the Drug

General Information of Drug (ID: DMW3MCX)

Drug Name

PRT811

Indication

Disease Entry	ICD 11	Status	REF
Glioma	2A00.0	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Protein arginine methyltransferase 5 (PRMT5)	TTR1D7X	ANM5_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04089449) A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Prelude Therapeutics.